Evidence map›Paper›PMID 32316464›Full record

ArticleCancers2020

Durable Complete Remission and Long-Term Survival in FDG-PET Staged Patients with Stage III Follicular Lymphoma, Treated with Wide-Field Radiation Therapy.

Michael P MacManus, Rodney J Hicks, Mathias Bressel, Belinda A Campbell, Andrew Wirth, Gail Ryan, H Miles Prince, Max Wolf, Rachel Brown, John F Seymour

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Michael P MacManusDepartment of Radiation Oncology Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.
Rodney J HicksSir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia.
Mathias BresselCentre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.
Belinda A CampbellDepartment of Radiation Oncology Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.ORCID 0000-0002-7316-8723
Andrew WirthDepartment of Radiation Oncology Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.
Gail RyanDepartment of Radiation Oncology Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.
H Miles PrinceSir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia.ORCID 0000-0002-0058-2448
Max WolfSir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia.
Rachel BrownDepartment of Radiation Oncology Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.
John F SeymourSir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia.ORCID 0000-0003-2188-6835
The University of Melbourne · AUThe Royal Melbourne Hospital · AUPeter MacCallum Cancer Centre · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advanced-stage follicular lymphoma (FL) is generally considered incurable with conventional systemic therapies, but historic series describe long-term disease-free survival in stage III disease treated with wide-field radiation therapy (WFRT), encompassing all known disease sites. We report outcomes for patients staged with

Indexed as

chemotherapyfollicular lymphomaradiation therapyrituximab

Identifiers

PMID32316464
PMCPMC7226391
OpenAlexW3016412966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.